Skip to main content

Perrigo Company plc (0Y5E.L)

London Stock Exchange Healthcare Medical - PharmaceuticalsView data quality →
48.1Fair

ValueMarkers Composite Index

Top 25%#33,570 of 44,707
Undervalued

99% below intrinsic value ($1,053)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.48
Low Risk
Altman
0.44
Distress
DCF Value
$1,053
Undervalued
ROIC
3.3%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Perrigo Company plc (0Y5E.L) — VMCI valuation read

The headline on Perrigo Company plc (0Y5E.L) is a 48/100 VMCI score, set against a Healthcare sector median of 50. That 2-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

0Y5E.L insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** 0Y5E.L trades at 19.0x earnings, 6% above the Healthcare median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 0.2x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on 0Y5E.L.

0Y5E.L fell 0.3% over the trailing 7 days, with a -12.8% read on a 30-day basis.

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

CEO: Patrick Lockwood-Taylor8,379 employeesIEwww.perrigo.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 0Y5E.L’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.